Generic Sweden AB (publ) OMXSTO:GENI:
Q3 NET SALES INCREASED BY 5.3% TO 45.3 MSEK
JUL-SEP EBIT INCREASED BY 15.2% TO 10.2 MSEK
Generic Sweden Q3 Net Sales SEK 45.3 Mln
Earlier from Generic Sweden
- Generic Sweden AB: Quarterly Trading Report 2025 Q3
- GENI: Strong EBIT growth and improved margins in Q2 2025, led by SaaS and secure communication services
- GENI: SaaS-driven margin growth and strong DOCS adoption boost results amid CEO transition
- GENI: Record revenue and profit growth in 2024, fueled by SaaS and public sector wins
- GENI: Record revenue and EBITDA in Q3 2024, driven by SaaS growth and strong demand
Later from Generic Sweden
- Generic Sweden Welcomes Jenny Björk As New CFO
- Generic Sweden Q4 EBIT Falls TO SEK 9.7 Mln
- GENI: Net sales rose 9.1% with robust digitalization growth, but cash flow turned negative on higher receivables
Follow Generic Sweden into a list and get an email when it puts out news.
Follow Generic Sweden